Polypharmacy Influences the Renal Composite Outcome in Patients Treated with Sodium‐Glucose Cotransporter 2 Inhibitors

Clinical and Translational Science ◽

10.1111/cts.13222 ◽

2022 ◽

Author(s):

Kazuo Kobayashi ◽

Masao Toyoda ◽

Nobuo Hatori ◽

Takayuki Furuki ◽

Hiroyuki Sakai ◽

...

Keyword(s):

Composite Outcome ◽

Sodium Glucose Cotransporter

Download Full-text

512-P: The Concomitant Insulin Treatment with Sodium–Glucose Cotransporter 2 Inhibitors Influenced the Renal Composite Outcome in Japanese Type 2 Diabetes Patients with Chronic Kidney Disease

Diabetes ◽

10.2337/db20-512-p ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 512-P

Author(s):

KAZUO KOBAYASHI ◽

MASAO TOYODA ◽

HIROYUKI SAKAI ◽

KOUICHI TAMURA ◽

NOBUO HATORI

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Insulin Treatment ◽

Composite Outcome ◽

Sodium Glucose Cotransporter ◽

Diabetes Patients

Download Full-text

Blood pressure after treatment with sodium–glucose cotransporter 2 inhibitors influences renal composite outcome: Analysis using propensity score‐matched models

Journal of Diabetes Investigation ◽

10.1111/jdi.13318 ◽

2020 ◽

Vol 12 (1) ◽

pp. 74-81

Author(s):

Kazuo Kobayashi ◽

Masao Toyoda ◽

Nobuo Hatori ◽

Takayuki Furuki ◽

Hiroyuki Sakai ◽

...

Keyword(s):

Blood Pressure ◽

Propensity Score ◽

Outcome Analysis ◽

Composite Outcome ◽

Sodium Glucose Cotransporter

Download Full-text

Sodium-glucose cotransporter 2 inhibitors in lipotoxicity correction Gogoleva S.P.

Endocrinology: News, Opinions, Training ◽

10.33029/2304-9529-2020-9-3-67-69 ◽

2020 ◽

Vol 9 (3) ◽

pp. 67-69

Author(s):

S.P. Gogoleva ◽

Keyword(s):

Sodium Glucose Cotransporter

Download Full-text

Changes in Blood Glucose Levels and Body Weight in Patients Administered Sodium-Glucose Cotransporter 2 Inhibitors

Diabetes ◽

10.2337/db18-1167-p ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 1167-P

Author(s):

HUN-SUNG KIM ◽

EUN YOUNG LEE ◽

KUN-HO YOON

Keyword(s):

Body Weight ◽

Blood Glucose ◽

Glucose Levels ◽

Blood Glucose Levels ◽

Sodium Glucose Cotransporter

Download Full-text

7-OR: Effect of Dapagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, on Vascular Function in Patients with Type 2 Diabetes Compared with Gliclazide

Diabetes ◽

10.2337/db19-7-or ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 7-OR

Author(s):

SOO LIM ◽

DAVID CHERNEY

Keyword(s):

Type 2 Diabetes ◽

Vascular Function ◽

Sodium Glucose Cotransporter

Download Full-text

88-LB: Similar Efficacy and Safety of IGlarLixi When Initiated in Patients with Type 2 Diabetes (T2D) with or without Concomitant Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in a Randomized Controlled Trial (RCT) and Real-World Setting

Diabetes ◽

10.2337/db20-88-lb ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 88-LB

Author(s):

JULIO ROSENSTOCK ◽

AMAR ALI ◽

JURIS J. MEIER ◽

FRANCESCO GIORGINO ◽

CRISTIAN GUJA ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Real World ◽

Controlled Trial ◽

Similar Efficacy ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Real World Setting ◽

Sodium Glucose Cotransporter

Download Full-text

Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes: a short review

International Journal of Medicine in Developing Countries ◽

10.24911/ijmdc.51-1599914173 ◽

2020 ◽

pp. 1993-1995

Author(s):

Ibrahim Ajwah ◽

Waleed Aloqbi ◽

Ahmed Ansari ◽

Nawaf Almalki ◽

Abdulelah Alonizei ◽

...

Keyword(s):

Short Review ◽

Cardiovascular Outcomes ◽

Sodium Glucose Cotransporter

Download Full-text

Safety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients With Type 2 Diabetes

Case Medical Research ◽

10.31525/ct1-nct04017221 ◽

2019 ◽

Author(s):

Keyword(s):

Type 2 Diabetes ◽

Sglt2 Inhibitors ◽

Sodium Glucose Cotransporter

Download Full-text

Faculty Opinions recommendation of Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718252271.793492697 ◽

2014 ◽

Author(s):

Emmanuel Bravo ◽

Mohammed Rafey

Keyword(s):

Metabolic Response ◽

Diabetic Patients ◽

Type 2 Diabetic Patients ◽

Sodium Glucose Cotransporter ◽

Type 2 Diabetic

Download Full-text

Faculty Opinions recommendation of Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727626288.793534797 ◽

2017 ◽

Author(s):

Shinya Goto

Keyword(s):

Heart Failure ◽

Comparative Effectiveness ◽

Lower Risk ◽

Cardiovascular Outcomes ◽

Glucose Lowering ◽

Sodium Glucose Cotransporter

Download Full-text